Cabozantinib in combination with immunotherapy for advanced kidney cancer

In this video interview, Dr Monty Pal from the City of Hope cancer centre in California, USA, talks about the clinical trials involving cabozantinib in combination with atezolizumab for clear cell and non-clear cell renal cell carcinoma (RCC).

Watch the video interview on Practice Update here


Share this Post!

Related post